Your browser doesn't support javascript.
loading
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
Ribera, Josep-Maria; Morgades, Mireia; Montesinos, Pau; Tormo, Mar; Martínez-Carballeira, Daniel; González-Campos, José; Gil, Cristina; Barba, Pere; García-Boyero, Raimundo; Coll, Rosa; Pedreño, María; Ribera, Jordi; Mercadal, Santiago; Vives, Susana; Novo, Andrés; Genescà, Eulàlia; Hernández-Rivas, Jesús-María; Bergua, Juan; Amigo, María-Luz; Vall-Llovera, Ferran; Martínez-Sánchez, Pilar; Calbacho, María; García-Cadenas, Irene; Garcia-Guiñon, Antoni; Sánchez-Sánchez, María-José; Cervera, Marta; Feliu, Evarist; Orfao, Alberto.
Afiliación
  • Ribera JM; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Morgades M; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Montesinos P; Departments of Clinical Hematology, Hospital Universitari i Politècnic La Fe, CIBERONC, Instituto Carlos III, Valencia, Spain, Madrid, Spain.
  • Tormo M; Departments of Clinical Hematology, Hospital Clínico Valencia, Valencia, Spain.
  • Martínez-Carballeira D; Hospital Central de Asturias, Oviedo, Spain.
  • González-Campos J; Departments of Clinical Hematology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Gil C; Departments of Clinical Hematology, Hospital General Universitario de Alicante, Alicante, Spain.
  • Barba P; Departments of Clinical Hematology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • García-Boyero R; Departments of Clinical Hematology, Hospital General Universitario de Castellón, Castelló, Spain.
  • Coll R; Departments of Clinical Hematology, ICO-Hospital Josep Trueta, Girona, Spain.
  • Pedreño M; Departments of Clinical Hematology, Hospital Dr. Peset, Valencia, Spain.
  • Ribera J; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Mercadal S; Departments of Clinical Hematology, ICO-Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Vives S; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Novo A; Departments of Clinical Hematology, Hospital Son Espases, Palma de Mallorca, Spain.
  • Genescà E; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hernández-Rivas JM; Departments of Clinical Hematology, Hospital Clínico Universitario, Cancer Research Center (IBMCC-CSIC/USAL), Cytometry Service CIBERONC, Salamanca, Spain.
  • Bergua J; Departments of Clinical Hematology, Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Amigo ML; Departments of Clinical Hematology, Hospital Morales Meseguer, Murcia, Spain.
  • Vall-Llovera F; Departments of Clinical Hematology, Hospital Mútua de Terrassa, Terrassa, Spain.
  • Martínez-Sánchez P; Departments of Clinical Hematology, Hospital Doce de Octubre, Madrid, Spain.
  • Calbacho M; Departments of Clinical Hematology, Hospital Ramón y Cajal, Madrid, Spain.
  • García-Cadenas I; Departments of Clinical Hematology, Hospital de Sant Pau, Barcelona, Spain.
  • Garcia-Guiñon A; Departments of Clinical Hematology, Hospital Arnau de Vilanova, Lleida, Spain.
  • Sánchez-Sánchez MJ; Departments of Clinical Hematology, Hospital Lucus Augusti, Lugo, Spain.
  • Cervera M; Departments of Clinical Hematology, ICO-Hospital Joan XXIII, Tarragona, Spain.
  • Feliu E; Departments of Clinical Hematology, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Orfao A; Departments of Clinical Hematology, Hospital Clínico Universitario, Cancer Research Center (IBMCC-CSIC/USAL), Cytometry Service CIBERONC, Salamanca, Spain.
Cancer Med ; 9(7): 2317-2329, 2020 04.
Article en En | MEDLINE | ID: mdl-32022463
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras / Recurrencia Local de Neoplasia Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasia Residual / Leucemia-Linfoma Linfoblástico de Células Precursoras / Recurrencia Local de Neoplasia Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: España